FLGT logo

Fulgent Genetics (FLGT) EBITDA

Annual EBITDA

-$67.45 M
-$281.61 M-131.49%

December 31, 2023

Summary

Performance

1-Year Change

-131.49%

3-Year Change

-123.01%

5-Year Change

-2220.26%

15-Year Change

-3745.5%

FLGT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.55%
FLGT annual EBITDA is higher than 26.55% of companies in Healthcare sector

High & Low

All-time High

$686.96 M
FLGT annual EBITDA is currently -109.82% below its historical high of $686.96 million

3-Year Low

-$67.45 M
FLGT annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FLGT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
FLGT next annual earnings announcement is scheduled for Feb 28, 2025

OtherFLGTprofitabilitymetrics:

Annual Revenue

$289.21 M
FLGT annual revenue is $289.21 million

Annual Net Income

-$167.82 M
FLGT annual net profit is -$167.82 million

Annual EBIT

-$75.30 M
FLGT annual earnings before interest & taxes is -$75.30 million

Annual EPS

-$5.63
FLGT annual earnings per share is -$5.63

Quarterly EBITDA

-$12.60 M
+$155.00 K+1.22%

September 30, 2024

Summary

Performance

3-Month Change

+1.22%

1-Year Change

-194.37%

3-Year Change

+52.95%

5-Year Change

+52.95%

FLGT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.27%
FLGT quarterly EBITDA is higher than 31.27% of companies in Healthcare sector

High & Low

All-time High

$268.84 M
FLGT quarterly EBITDA is currently -104.69% below its historical high of $268.84 million

3-Year Low

-$40.50 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FLGT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FLGT next earnings announcement is scheduled for Feb 28, 2025

OtherFLGTprofitabilitymetrics:

Quarterly Revenue

$71.74 M
FLGT quarterly revenue is $71.74 million

Quarterly Net Income

-$14.65 M
FLGT quarterly net profit is -$14.65 million

Quarterly EBIT

-$18.52 M
FLGT quarterly earnings before interest & taxes is -$18.52 million

Quarterly EPS

-$0.48
FLGT quarterly earnings per share is -$0.48

TTM EBITDA

-$80.98 M
-$25.95 M-47.14%

September 30, 2024

Summary

Performance

3-Month Change

-47.14%

1-Year Change

-80.53%

3-Year Change

-137.81%

5-Year Change

-137.81%

FLGT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.12%
FLGT TTM EBITDA is higher than 22.12% of companies in Healthcare sector

High & Low

All-time High

$759.64 M
FLGT TTM EBITDA is currently -110.66% below its historical high of $759.64 million

3-Year Low

-$80.98 M
FLGT TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FLGT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FLGT next earnings announcement is scheduled for Feb 28, 2025

OtherFLGTprofitabilitymetrics:

TTM Revenue

$277.76 M
FLGT TTM revenue is $277.76 million

TTM Net Income

-$164.97 M
FLGT TTM net profit is -$164.97 million

TTM EBIT

-$106.25 M
FLGT TTM earnings before interest & taxes is -$106.25 million

TTM EPS

-$5.52
FLGT TTM earnings per share is -$5.52

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$67.45 M
FLGT annual EBITDA is -$67.45 million

Annual Net Income

-$167.82 M
FLGT annual net profit is -$167.82 million

Annual Interest Expense

-
FLGT annual interest expense value is unknown

Annual Income Tax

$1.15 M
FLGT annual income tax is $1.15 million

Annual D&A

$26.14 M
FLGT annual depreciation & amortization is $26.14 million

FLGT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-131.5%-194.4%-80.5%
3 y3 years-123.0%+53.0%-137.8%
5 y5 years-2220.3%+53.0%-137.8%

FLGT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-109.8%at low-106.1%+68.9%-111.8%at low
5 y5-year-109.8%at low-104.7%+68.9%-110.7%at low
alltimeall time-109.8%at low-104.7%+68.9%-110.7%at low

Fulgent Genetics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$12.60 M(-1.2%)
-$80.98 M(+47.1%)
Jun 2024
-
-$12.75 M(-15.7%)
-$55.04 M(-1.3%)
Mar 2024
-
-$15.13 M(-62.6%)
-$55.77 M(-4.8%)
Dec 2023
-$67.45 M(-131.5%)
-$40.50 M(-403.4%)
-$58.58 M(+30.6%)
Sep 2023
-
$13.35 M(-199.0%)
-$44.86 M(-6.4%)
Jun 2023
-
-$13.49 M(-24.8%)
-$47.93 M(+360.5%)
Mar 2023
-
-$17.95 M(-33.0%)
-$10.41 M(-104.9%)
Dec 2022
$214.16 M(-68.8%)
-$26.78 M(-360.5%)
$214.16 M(-45.8%)
Sep 2022
-
$10.28 M(-57.2%)
$395.29 M(-27.8%)
Jun 2022
-
$24.04 M(-88.4%)
$547.46 M(-12.4%)
Mar 2022
-
$206.63 M(+33.9%)
$624.74 M(-9.1%)
Dec 2021
$686.96 M(+134.4%)
$154.35 M(-5.0%)
$686.96 M(-9.6%)
Sep 2021
-
$162.45 M(+60.3%)
$759.64 M(+14.8%)
Jun 2021
-
$101.32 M(-62.3%)
$661.44 M(+17.4%)
Mar 2021
-
$268.84 M(+18.4%)
$563.31 M(+92.2%)
Dec 2020
$293.12 M(>+9900.0%)
$227.03 M(+253.4%)
$293.12 M(+342.5%)
Sep 2020
-
$64.25 M(+1914.6%)
$66.24 M(+1553.9%)
Jun 2020
-
$3.19 M(-337.1%)
$4.00 M(+146.9%)
Mar 2020
-
-$1.34 M(-1002.7%)
$1.62 M(-3.4%)
DateAnnualQuarterlyTTM
Dec 2019
$1.68 M(-157.8%)
$149.00 K(-92.6%)
$1.68 M(+61.6%)
Sep 2019
-
$2.01 M(+149.6%)
$1.04 M(-181.7%)
Jun 2019
-
$806.00 K(-162.6%)
-$1.27 M(-49.5%)
Mar 2019
-
-$1.29 M(+162.3%)
-$2.52 M(-13.4%)
Dec 2018
-$2.91 M(+65.7%)
-$491.00 K(+64.2%)
-$2.91 M(-27.6%)
Sep 2018
-
-$299.00 K(-31.9%)
-$4.01 M(-15.6%)
Jun 2018
-
-$439.00 K(-73.8%)
-$4.76 M(+17.1%)
Mar 2018
-
-$1.68 M(+5.1%)
-$4.06 M(+131.6%)
Dec 2017
-$1.75 M(-184.0%)
-$1.60 M(+53.1%)
-$1.75 M(-215.3%)
Sep 2017
-
-$1.04 M(-509.0%)
$1.52 M(-30.0%)
Jun 2017
-
$255.00 K(-59.6%)
$2.17 M(-30.7%)
Mar 2017
-
$631.00 K(-62.4%)
$3.13 M(+50.1%)
Dec 2016
$2.09 M(-147.1%)
$1.68 M(-528.1%)
$2.09 M(-131.0%)
Sep 2016
-
-$392.00 K(-132.2%)
-$6.74 M(+34.9%)
Jun 2016
-
$1.22 M(-392.8%)
-$5.00 M(-19.6%)
Mar 2016
-
-$416.00 K(-94.2%)
-$6.22 M(+7.2%)
Dec 2015
-$4.44 M(+458.8%)
-$7.15 M(-629.5%)
-$5.80 M(-529.5%)
Sep 2015
-
$1.35 M
$1.35 M
Dec 2014
-$794.00 K
-
-

FAQ

  • What is Fulgent Genetics annual EBITDA?
  • What is the all time high annual EBITDA for Fulgent Genetics?
  • What is Fulgent Genetics annual EBITDA year-on-year change?
  • What is Fulgent Genetics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Fulgent Genetics?
  • What is Fulgent Genetics quarterly EBITDA year-on-year change?
  • What is Fulgent Genetics TTM EBITDA?
  • What is the all time high TTM EBITDA for Fulgent Genetics?
  • What is Fulgent Genetics TTM EBITDA year-on-year change?

What is Fulgent Genetics annual EBITDA?

The current annual EBITDA of FLGT is -$67.45 M

What is the all time high annual EBITDA for Fulgent Genetics?

Fulgent Genetics all-time high annual EBITDA is $686.96 M

What is Fulgent Genetics annual EBITDA year-on-year change?

Over the past year, FLGT annual EBITDA has changed by -$281.61 M (-131.49%)

What is Fulgent Genetics quarterly EBITDA?

The current quarterly EBITDA of FLGT is -$12.60 M

What is the all time high quarterly EBITDA for Fulgent Genetics?

Fulgent Genetics all-time high quarterly EBITDA is $268.84 M

What is Fulgent Genetics quarterly EBITDA year-on-year change?

Over the past year, FLGT quarterly EBITDA has changed by -$25.95 M (-194.37%)

What is Fulgent Genetics TTM EBITDA?

The current TTM EBITDA of FLGT is -$80.98 M

What is the all time high TTM EBITDA for Fulgent Genetics?

Fulgent Genetics all-time high TTM EBITDA is $759.64 M

What is Fulgent Genetics TTM EBITDA year-on-year change?

Over the past year, FLGT TTM EBITDA has changed by -$36.13 M (-80.53%)